Locations:
Search IconSearch
September 14, 2018/Cancer

End-of-Life Conversations: Advice from a Palliative Care Physician

A Q&A with Laura Shoemaker, DO

Elderly patient's hands

Q. What do you wish others knew about having such conversations?

Dr. Shoemaker: First, I wish physicians appreciated how much patients want their doctors to start the conversation. Doing so does not dash hope or create anxiety. Instead, initiating the conversation demonstrates sincere interest and respect. It can lead to better outcomes and lessen family stress near the end of life.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Second, “the conversation” is the essential piece of advance care planning. Completing documents without the associated meaningful conversations with loved ones falls short of the goal. The Conversation Project website is a fantastic help! My family used it and I refer my patients there regularly after I’ve initiated the conversation in my clinic.

Q. Palliative care is often confused with hospice. What are the differences?

Dr. Shoemaker: Most healthcare professionals do understand that there is a difference and want to guide patients appropriately, but because they don’t totally get the difference, I hear things like “this patient is not ready for palliative care” or “this patient is ‘going palliative’ instead of hospice.”

Palliative care is appropriate for any patient suffering with serious illness, regardless of age or stage. The goal is to improve quality of life for both the patient and the family. Palliative care is provided by a specially trained team of doctors, nurses and other specialists who work together with a patient’s other doctors to provide an extra layer of support. It can be provided along with curative treatment.

If you ask most patients and families if they would like additional support from a doctor or nurse who specializes in improving their quality of life while they live with the physical, emotional and spiritual burdens of serious illness, most will say yes. Hospice, which falls under the umbrella of palliative care, is conservative, comfort-focused care for patients with a life-limiting disease and a prognosis of months or less.

Advertisement

Q. Have you had to discuss end-of-life with any of your family members?

Dr. Shoemaker: I talk with patients and families every day about their care goals and preferences, but when it comes to family, I sometimes find myself tongue-tied. Last fall Ellen Goodman came to Cleveland to discuss the The Conversation Project. I went with my parents and this gave us the stimulus and tools we needed to turn abstract conversations into concrete ones. We had our best conversation in the car on the way home. We then included my brother in the conversations during Thanksgiving, and now the advance directive paperwork is done too.

Q. Why do you choose to practice at Cleveland Clinic?

Dr. Shoemaker: Because it is a place where I feel confident bringing my own family for care. It feels good to work among colleagues practicing at the top of their fields. Cleveland Clinic is an extremely collegial place, where staff go out of their way to help patients and co-workers.

Q. Something your colleagues may be surprised to learn about you?

Dr. Shoemaker: I love competitive sports. I play tennis and softball, as well as I can at this age, and enjoy almost any spectator sport, including college football (Go Blue!), professional football, basketball and baseball. I’m pretty loyal to Cleveland teams.

Q. Advice you would give to your 20-year-old self?

Dr. Shoemaker: Spend a little more time in the moment.

Advertisement

Related Articles

Dr. Pennell and patient
April 10, 2025/Cancer/News & Insight
BiTE Therapy Emerges for Treating Small-Cell Lung Cancer

Hybrid treatment model helps improve cancer care access

Immune checkpoint inhibitor illustration
April 8, 2025/Cancer
Building on Initial Trial Data about New Immune Checkpoint Inhibitor for Treating Colorectal Cancer

Insights indicate that treatment may be beneficial beyond MSI-H tumors

Dr. Gerds with a patient
April 7, 2025/Cancer/News & Insight
Positive Results from Prospective, Randomized, Phase 3 Registrational Trial of Pelabresib + Ruxolitinib for JAK Inhibitor-Naive Myelofibrosis

Combination therapy doubles the number of meaningful spleen volume responses over monotherapy

Baby's feet
April 3, 2025/Cancer/News & Insight
Fertility Preservation Counseling for Young Adults with Cancer

Growing need for addressing fertility concerns

CAR T cell
March 28, 2025/Cancer/News & Insight
What’s New and on the Horizon for Treating Multiple Myeloma?

Making sense of the fast-moving treatment landscape

Myelofibrosis cells
March 18, 2025/Cancer/News & Insight
Personalizing Treatment of Myelofibrosis-Associated Anemia

Combination therapy may help address underlying disease

Basal cell carcinoma
March 14, 2025/Cancer/News & Insight
Definitive Radiation Therapy Effective for Treating Locally Advanced Basal Cell Carcinoma

Major study demonstrates importance of having a multidisciplinary approach to treatment for large, locally advanced tumors

PET scan
March 4, 2025/Cancer/News & Insight
Case Study: First Patient at Cleveland Clinic Treated with Tumor-Infiltrating Lymphocyte Therapy

Highly personalized treatment shrinks tumors resistant to immunotherapy

Ad